News
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...
1d
Pharmaceutical Technology on MSNKling Bio and Sanofi link for antibodies and epitopes discoveryUsing patient-derived B cells, Kling-Select facilitates the rapid detection of new antibodies and preserved viral epitopes.
Explore more
The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...
A soon-to-be-released documentary film aims to change the conversation around hemophilia, a condition in which many female ...
Last month, a vaccine panel with members handpicked by Kennedy voted in favor of Americans receiving seasonal flu shots that ...
The decision follows last month’s vote of the CDC’s revamped vaccine advisory committee. Thimerosal, mostly removed from ...
Thermo Fisher beat Q2 estimates, raised its 2025 guidance, and announced a CFO transition as easing tariffs support an improved outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results